Clinical effect of transcatheter arterial chemoembolization combined with tegafur, gimeracil, and oteracil potassium in treatment of advanced hepatocellular carcinoma
Objective To evaluate the clinical effect of transcatheter arterial chemoembolization ( TACE) alone or combined with tegafur, gimeracil, and oteracil potassium ( S- 1) in the treatment of advanced hepatocellular carcinoma ( HCC) . Methods Sixty patients with unresectable advanced HCC, who were admitted to our hospital from August 2009 to October 2010, were randomly divided into treatment group ( n =30) and control group ( n =30) . The treatment group was treated with TACE combined with oral S-1, and the control group with TACE alone. The response rates, disease control rates, survival rates, and adverse reactions of both groups were evaluated. Categorical data were analyzed by chi- square test; survival analysis was performed by Log- rank test. Results Compared with the control group, the treatment group had a significantly higher response rate ( 63. 3% vs 33. 3%, χ2= 5. 406, P = 0. 020) , a significantly higher disease control rate ( 86. 7% vs 43. 3%, χ2= 12. 308, P = 0. 000) , a significantly higher 1- year survival rate ( 77. 3% vs 51. 5%, χ2= 4. 593, P = 0. 032) , and a significantly higher 2- year survival rate ( 34. 8% vs 10. 4%, χ2= 4. 812, P = 0. 028) . Mild adverse reactions ( grade Ⅰ or Ⅱ) were seen in the two groups, including nausea, vomiting, diarrhea, and bone marrow suppression. These adverse reactions could be reduced by symptomatic treatment and showed no significant differences between the two groups ( P > 0. 05) . Conclusion The combination therapy with S- 1 plus TACE is effective in the treatment of advanced HCC and is worth further study.
KIM SJ, HAN SW, OH DY, et al.Combination chemotherapy with S-1 and platinum in advanced hepatocellular carcinoma[J].Anticancer Res, 2010, 30 (12) :5245-5250. MORISE Z, SUGIOKA A, FUJITA J, et al.S-1 plus cisplatin combination therapy for the patients with primary liver carcinomas[J].Hepatogastroenterology, 2007, 54 (80) :2315-2318. NAKAMURA M, NAGANO H, MARUBASHI S, et al.S-1 treatment against advanced HCC[J].Gan To Kagaku Ryoho, 2006, 33 (Suppl 1) :230-235. KATAMURA Y, AIKATA H, HASHIMOTO Y, et al.Pilot study of systemic combination therapy with S-1, an oral fluoropyrimidine, and cisplatin for hepatocellular carcinoma with extrahepatic metastases[J].Hepatogastroenterology, 2010, 57 (102-103) :1272-1278. YAMADA D, WADA H, KOBAYASHI S, et al.A long-term survival case of hepatocellular carcinoma with bone metastasis and inferior vena cava tumor thrombus successfully treated with multidisciplinary therapy[J].Gan To Kagaku Ryoho, 2010, 37 (12) :2670-2267. YANG BH, XIA JL.Clinical diagnosis and staging criteria for primary liver cancer[J].Chin J Hepatol, 2001, 9 (6) :324. (in Chinese) 杨秉辉, 夏景林.原发性肝癌的临床诊断与分期标准[J].中华肝脏病杂志, 2001, 9 (6) :324.  MAO JW.Current situation and progress in minimally inva-sive therapy for primary liver cancer[J].Chin Modern Med, 2005, 3 (7) :29-31. (in Chinese) 毛金武.原发性肝癌微创治疗的现状及进展[J].中华当代医学, 2005, 3 (7) :29-31. LYU HF, ZHANG YX, HAN LL, et al.Clinical observation of Oxaliplatin combined with Gimeracil or Capecitabine in the treatment of advanced gastric cancer in elderly patients[J].China Med Herald, 2012, 9 (23) :61-63. (in Chinese) 吕慧芳, 张延新, 韩黎丽, 等.奥沙利铂联合替吉奥或卡培他滨治疗老年晚期胃癌的临床观察[J].中国医药导报, 2012, 9 (23) :61-63. BLUM M, SUZUKI A, AJANI JA.A comprehensive review of S-1 in the treatment of advanced gastric adenocarcinoma[J].Future Oncol, 2011, 7 (6) :715-726. SAIF MW, SYRIGOS KN, KATIRTZOGLOU NA.S-1:a promising new oral fluoropyrimidine derivative[J].Expert Opin Investig Drugs, 2009, 18 (3) :335-348. LIU JH, QI SM, CHEN GJ, et al.Compourd tegafur capsules for clinical research progress[J].China Modern Doctor, 2008, 46 (30) :62-63.刘江华, 戚苏明, 陈国俊, 等.替吉奥胶囊临床研究进展[J].中国现代医生, 2008, 46 (30) :62-63. VARGA M, VALSAMIS A, MATIA I, et al.Transarterial chemoembolization in hepatocellular carcinoma[J].Rozhl Chir, 2009, 88 (8) :434-438. LAN CH, WANG CY.Progress of TACE for primary liver cancer[J].Current Physician, 2009, 3 (4) :500-502.兰春虎, 王常友.原发性肝癌TACE治疗进展[J].当代医学, 2009, 3 (4) :500-502. CHEN CN, PAN QZ, HUANG HX, et al.Clinical effect of whole-body hyperthermia combined with transcatheter arterial chemoembolization in treatment of advanced liver cancer[J].J Clin Hepatol, 2006, 33 (3) :220. (in Chinese) 陈昌南, 潘岐作, 黄活勋, 等.体外热疗与TACE结合治疗中晚期肝癌的临床研究[J].临床肝胆病杂志, 2006, 33 (3) :220.
- 文章访问数: 2706
- HTML全文浏览量: 10
- PDF下载量: 585
- 被引次数: 0